SciSparc (SPRC) Revenue & Revenue Breakdown
SciSparc Revenue Highlights
Latest Revenue (Y)
$2.88M
Latest Revenue (Q)
$907.00K
SciSparc Revenue by Period
SciSparc Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $2.88M | 113.73% |
2022-12-31 | $1.35M | 26.01% |
2021-12-31 | $1.07M | 94.36% |
2020-12-31 | $550.00K | 10.44% |
2019-12-31 | $498.00K | -40.57% |
2018-12-31 | $838.00K | 72.07% |
2017-12-31 | $487.00K | 100.00% |
2016-12-31 | - | 100.00% |
2015-12-31 | - | 100.00% |
2014-12-31 | - | 100.00% |
2013-12-31 | - | 100.00% |
2012-12-31 | - | - |
SciSparc Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2023-12-31 | $907.00K | -54.01% |
2023-06-30 | $1.97M | 46.40% |
2022-12-31 | $1.35M | 100.00% |
2022-06-30 | - | -100.00% |
2021-12-31 | $1.07M | 100.00% |
2021-06-30 | - | -100.00% |
2020-12-31 | $550.00K | 100.00% |
2020-06-30 | - | -100.00% |
2019-12-31 | $498.00K | 100.00% |
2019-06-30 | - | 100.00% |
2019-03-31 | - | -100.00% |
2018-12-31 | $838.00K | 100.00% |
2018-09-30 | - | 100.00% |
2018-06-30 | - | 100.00% |
2018-03-31 | - | -100.00% |
2017-12-31 | $487.00K | 100.00% |
2017-09-30 | - | 100.00% |
2017-06-30 | - | 100.00% |
2017-03-31 | - | 100.00% |
2016-12-31 | - | 100.00% |
2016-09-30 | - | 100.00% |
2016-06-30 | - | 100.00% |
2016-03-31 | - | 100.00% |
2015-12-31 | - | 100.00% |
2015-09-30 | - | 100.00% |
2015-06-30 | - | 100.00% |
2015-03-31 | - | 100.00% |
2014-12-31 | - | 100.00% |
2014-09-30 | - | 100.00% |
2014-06-30 | - | 100.00% |
2013-12-31 | - | - |
SciSparc Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
YS | LakeShore Biopharma | $687.20M | $164.98M |
CTMX | CytomX Therapeutics | $101.21M | $25.11M |
ASMB | Assembly Biosciences | $7.16M | $5.79M |
SPRC | SciSparc | $2.88M | $907.00K |
UNCY | Unicycive Therapeutics | $675.00K | - |
VRAX | Virax Biolabs Group | $8.56K | $76.50K |
PXMD | PaxMedica | - | - |
TIL | Instil Bio | - | - |
REVB | Revelation Biosciences | - | - |
HILS | Tharimmune | - | - |
CVKD | Cadrenal Therapeutics | - | - |
NLTX | Neurogene | - | - |
HOTH | Hoth Therapeutics | - | - |
ZVSA | ZyVersa Therapeutics | - | - |
ONCS | OncoSec Medical | - | - |
VIRI | Virios Therapeutics | - | - |
NUVB | Nuvation Bio | - | $1.44M |
QNRX | Quoin Pharmaceuticals | - | - |
KPRX | Kiora Pharmaceuticals | - | $20.00K |
CDIO | Cardio Diagnostics | - | $7.87K |
BWV | Onconetix | - | - |
SPRC Revenue FAQ
What is SciSparc’s yearly revenue?
SciSparc's yearly revenue for 2023 was $2.88M, representing an increase of 113.73% compared to 2022. The company's yearly revenue for 2022 was $1.35M, representing an increase of 26.01% compared to 2021. SPRC's yearly revenue for 2021 was $1.07M, representing an increase of 94.36% compared to 2020.
What is SciSparc’s quarterly revenue?
SciSparc's quarterly revenue for Q4 2023 was $907K, a -54.01% decrease from the previous quarter (Q2 2023), and a -15.15% decrease year-over-year (Q4 2021). The company's quarterly revenue for Q2 2023 was $1.97M, a 46.40% increase from the previous quarter (Q4 2022), and a 0% increase year-over-year (Q2 2021). SPRC's quarterly revenue for Q4 2022 was $1.35M, a 100.00% increase from the previous quarter (Q2 2022), and a 144.91% increase year-over-year (Q4 2020).
What is SciSparc’s revenue growth rate?
SciSparc's revenue growth rate for the last 3 years (2021-2023) was 169.32%, and for the last 5 years (2019-2023) was 478.11%.